Byggma ASA (BMA.OL)
NOK 16.6
(-2.35%)
NOK 16.6
(-2.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 220.8 Million | 314.97 Million | 139.08 Million | 207.07 Million | 78.89 Million | 53.01 Million |
| Net Income | 61 Million | 250.21 Million | 174.05 Million | 124.9 Million | 48.94 Million | 46.78 Million |
| Depreciation & Amortization | 90.3 Million | 82.03 Million | 89.93 Million | 77.06 Million | 70.13 Million | 54.22 Million |
| Deferred income taxes | -52.91 Million | - | - | 2.86 Million | 8.79 Million | 1.08 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 61.92 Million | 48.1 Million | -125.11 Million | -39.56 Million | -38.47 Million | -24.79 Million |
| Other non-cash items | 250.1 Million | -65.37 Million | 210 Thousand | 44.66 Million | -1.71 Million | -23.2 Million |
| Investing Cash Flow | -162.8 Million | -1.13 Billion | -51.52 Million | -87.37 Million | -112.72 Million | -104.08 Million |
| Investments in PPE | -77.2 Million | -130.51 Million | -90.35 Million | -61.18 Million | -92.11 Million | -105.36 Million |
| Acquisitions | 1 Million | 15.37 Million | 50 Thousand | 1.01 Million | -21.47 Million | 1.27 Million |
| Investment purchases | -87.2 Million | -1.01 Billion | - | - | - | - |
| Sales/Maturities of investments | 12.2 Million | -15.37 Million | - | - | - | - |
| Other Investing Activities | 600 Thousand | 14.99 Million | 38.78 Million | -27.2 Million | 862 Thousand | 1.27 Million |
| Financing Cash Flow | -32.9 Million | 783.68 Million | -538.1 Million | 77.71 Million | -18.06 Million | 67.77 Million |
| Debt repayment | -32.9 Million | -87.52 Million | -67.2 Million | -62 Million | -49.26 Million | -86.13 Million |
| Dividends payments | - | -69.81 Million | -558.55 Million | -6.98 Million | -7.02 Million | -7.16 Million |
| Common Stock Repurchased | - | - | - | -139 Thousand | -3.95 Million | -11.06 Million |
| Common Stock Issuance | - | - | - | 146.84 Million | 54.04 Million | - |
| Other Financing Activities | 74.2 Million | 941.03 Million | 87.65 Million | -1000.00 | -11.86 Million | -128 Thousand |
| Accounts receivables | 4.25 Million | 66.08 Million | -107.78 Million | -113 Million | 13.04 Million | -32.77 Million |
| Accounts payables | 17.3 Million | 12.54 Million | 79.59 Million | 42.64 Million | -33.65 Million | 50.61 Million |
| Inventory | 40.36 Million | -30.52 Million | -96.93 Million | 30.79 Million | -17.87 Million | -42.31 Million |
| Other working capital | 17.3 Million | - | - | -1000.00 | - | 17.52 Million |
| Cash at beginning of period | 37.07 Million | 70.96 Million | 525.22 Million | 322.59 Million | 377.03 Million | 358.87 Million |
| Cash at end of period | 63.2 Million | 37.07 Million | 70.96 Million | 525.22 Million | 322.59 Million | 377.03 Million |
| Capital Expenditure | -77.2 Million | -130.51 Million | -90.35 Million | -61.18 Million | -92.11 Million | -105.36 Million |
| Effect of forex changes on cash | 1.03 Million | -698 Thousand | -3.71 Million | 5.22 Million | -2.54 Million | 1.45 Million |
| Net cash flow / Change in cash | 26.12 Million | -33.88 Million | -454.26 Million | 202.63 Million | -54.44 Million | 18.16 Million |
| Free Cash Flow | 143.6 Million | 184.46 Million | 48.72 Million | 145.89 Million | -13.21 Million | -52.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 56.4 Million | -103.8 Million | 108.9 Million | 61 Million | 55.7 Million | 28 Million |
| Depreciation & Amortization | 22.2 Million | 22.2 Million | 53.1 Million | 90.3 Million | 22 Million | 22.1 Million |
| Deferred income taxes | - | - | -52.91 Million | -52.91 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 44.61 Million | 61.92 Million | - | - |
| Other non-cash items | -8.8 Million | 115.4 Million | 37 Million | 250.1 Million | -32.9 Million | 53.9 Million |
| Investing Cash Flow | -7.2 Million | -4.4 Million | -18.9 Million | -162.8 Million | -16.2 Million | -50.4 Million |
| Investments in PPE | -7.1 Million | -4.5 Million | -20.3 Million | -77.2 Million | -16.3 Million | -27.1 Million |
| Acquisitions | - | - | 700 Thousand | 1 Million | 200 Thousand | -23.3 Million |
| Investment purchases | - | - | 46 Thousand | -87.2 Million | - | -23.3 Million |
| Sales/Maturities of investments | - | - | 12.2 Million | 12.2 Million | - | - |
| Other Investing Activities | -100 Thousand | 100 Thousand | 600 Thousand | 600 Thousand | -100 Thousand | 23.3 Million |
| Financing Cash Flow | -15.3 Million | -23 Million | -43.6 Million | -32.9 Million | -18.6 Million | -50.5 Million |
| Debt repayment | -15.3 Million | -23 Million | -43.7 Million | -32.9 Million | -18 Million | -66.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -48.5 Million | 38.8 Million | -27.5 Million | 74.2 Million | -600 Thousand | 16 Million |
| Accounts receivables | - | - | 4.25 Million | 4.25 Million | - | - |
| Accounts payables | - | - | - | 17.3 Million | - | - |
| Inventory | - | - | 40.36 Million | 40.36 Million | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 25.2 Million | 63.2 Million | 32.29 Million | 37.07 Million | 22.6 Million | 19.7 Million |
| Cash at end of period | 28 Million | 25.2 Million | 63.2 Million | 63.2 Million | 32.3 Million | 22.6 Million |
| Capital Expenditure | -7.1 Million | -4.5 Million | -20.3 Million | -77.2 Million | -16.3 Million | -27.1 Million |
| Effect of forex changes on cash | -100 Thousand | - | 535 Thousand | 1.03 Million | -200 Thousand | -200 Thousand |
| Net cash flow / Change in cash | 2.8 Million | -38 Million | 30.9 Million | 26.12 Million | 9.7 Million | 2.9 Million |
| Free Cash Flow | 18.3 Million | -15.1 Million | 72.5 Million | 143.6 Million | 28.5 Million | 76.9 Million |
CIOXY
8180
ALKYLAMINE
000584
001225
SURE